Trials / Completed
CompletedNCT03068702
New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA)
New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA): Sickle Cell Maculopathy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2 (actual)
- Sponsor
- Dr. S.S. Michel Clinic · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Sickle cell maculopathy was sparingly mentioned in the literature before despite the fact that sickle cell disease or sickle cell trait is common in people of many areas of the world. This study shows that OCTA is a very valuable, non invasive, office procedure that may well be used in diagnosing this disease.
Detailed description
this is a clinical study of two African Canadian patients that were diagnosed with sickle cell trait. I used OCTA to show macular vascular occlusions that usually happen with this disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Optical Coherence Tomography Angiography |
Timeline
- Start date
- 2016-08-21
- Primary completion
- 2017-01-12
- Completion
- 2017-02-21
- First posted
- 2017-03-03
- Last updated
- 2017-03-03
Source: ClinicalTrials.gov record NCT03068702. Inclusion in this directory is not an endorsement.